Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:38 PM ET 8-K
Leadership Change Sidus Space Inc. SIDU

Sidus Space Leadership Change

Sidus Space, Inc. appointed Mark R. Malek to its Board of Directors, effective November 11, 2026. Mr. Malek will also serve on the Corporate Governance/Nominating Committee and hold his board seat until the 2027 annual meeting of stockholders.

Counterparty
Mark R. Malek
4:38 PM ET 8-K
Other 8-K Filing Bnb Plus Corp. BNBX

Bnb Plus Other 8-K Filing

BNB Plus Corp. entered into a Conversion and Inducement Agreement where holders of Series B-1 Preferred Stock converted 1,282,852 shares into common stock on a one-for-one basis. As an inducement for the conversion, the company paid the holders an aggregate cash payment of approximately $2.02 million ($1.575 per share). This transaction represents a preferred equity redemption settled in common stock with a cash inducement, rather than a new capital raise or debt issuance.

Counterparty
Holders of Series B-1 Preferred Stock
4:37 PM ET 8-K
Leadership Change Weyerhaeuser Co WY

Weyerhaeuser Leadership Change

Denise Merle will retire as Senior Vice President and Chief Administration Officer effective December 31, 2026. She will be succeeded by Cristin Aragon, appointed as SVP and Chief Human Resources Officer, and Justin Nikbakhsh, appointed as SVP of Technology and Procurement, both effective January 1, 2027. Merle will remain as a strategic advisor during the transition period.

4:37 PM ET Form 4
Insider Selling Vertex Pharmaceuticals Inc VRTX

Vertex Pharmaceuticals EVP, Co & Fo Charles F. Wagner Jr. Sells $8.37M of Stock

Charles F. Wagner Jr., EVP, Co & Fo, sold 15,286 shares of Vertex Pharmaceuticals Inc at $547.87 a share, worth $8.37M in total on Nov 12, 2026. Shares held after the trade: 31,764 (-32.5%).

Value
$8.37M
Shares
15,286
Price
$547.87
Role
EVP, Co & Fo
Holding change
-32.5%
Trade date
Nov 12, 2026
4:37 PM ET 8-K
Investor Presentation UDR, Inc. UDR

UDR Investor Presentation

UDR, Inc. filed formal presentation materials to be made available to investors starting November 16, 2026. The filing was made under Item 7.01 (Regulation FD Disclosure) and includes an exhibit of the presentation materials.

4:37 PM ET 8-K
M&A Deal Aethlon Medical Inc AEMD

Aethlon Medical M&A Deal with North Immunology, Inc.

Aethlon Medical provided a status update on its pending merger with North Immunology, Inc., originally announced on September 17, 2026. The filing includes an updated investor presentation that North Immunology will use in meetings with investors regarding the transaction and a concurrent private placement.

Counterparty
North Immunology, Inc.
4:37 PM ET 8-K
Loan & Debt Sonic Automotive Inc SAH

Sonic Automotive $850M Debt Financing with PNC Bank, National Association

Sonic Automotive entered into a $850 million Consolidated, Amended and Restated Credit Agreement with PNC Bank to consolidate and refinance its existing mortgage and sidecar debt facilities. The new facility consists of a $750 million term loan and a $100 million revolving credit facility, both maturing on November 10, 2031. The company immediately borrowed the full $750 million under the term loan facility on the closing date.

Value
$850M
Counterparty
PNC Bank, National Association
Term
5 years
4:37 PM ET 8-K
Business Update Hyperscale Data, Inc. GPUS

Hyperscale Data Business Update

Hyperscale Data announced preliminary unaudited revenue of approximately $44.8 million for the third quarter of 2026, an 84% increase year-over-year. The company provided this update ahead of its formal earnings announcement and scheduled Investor Day on November 23, 2026. The results exceeded the company's previous estimate of $40 million for the period.

4:37 PM ET 8-K
Investor Presentation Invitation Homes Inc. INVH

Invitation Homes Investor Presentation

Invitation Homes Inc. filed a formal investor presentation for meetings in November 2026, highlighting its capital allocation strategy and portfolio performance. The company disclosed it has repurchased $1.0 billion of its stock since December 2025, funded primarily by home sales in high-value markets like Southern California and South Florida. The presentation also reaffirmed October 2026 leasing stats, showing 96.1% occupancy and 2.2% blended rental rate growth.

4:37 PM ET 8-K
Financial Results Precision Optics Corporation, Inc. POCI

Precision Optics Corporation Financial Results

Precision Optics reported Q1 2027 revenue growth of 22% year-over-year to $8.2 million, driven by strong performance in satellite optical communications and single-use medical device programs. The company's net loss narrowed significantly to $0.5 million compared to $1.6 million in the prior year, while gross margins improved to 22.5%.

Term
Q1 2027

“Revenue grew 22% year over year to $8.2 million, led by a 23% increase in production revenue. Higher volumes and more efficient manufacturing helped lift gross margin and improved our Adjusted EBITDA.”

Dr. Joe Forkey, CEO of Precision Optics

“We continued to make operational progress with our single-use medical device programs. The cystoscope program generated $1.8 million in production revenue, and our ophthalmic program delivered revenue of $581,000, as shipments increased under its $3.5 million follow-on order.”

Dr. Joe Forkey, CEO of Precision Optics
4:37 PM ET 8-K
Leadership Change Fuller H B Co FUL

Fuller H B Leadership Change

Robert J. Martsching resigned as Vice President, Corporate Controller, and principal accounting officer effective November 9, 2026. The Board appointed Sarah R. Nickless, previously the Director of Financial Planning & Analysis, to succeed him in these roles. Mr. Martsching will remain with the company through January 2027 to assist with the financial integration of the pending acquisition of Advanced Medical Solutions Group plc.

4:37 PM ET 8-K
Shareholder Meeting Conexeu Sciences Inc. CNXU

Conexeu Sciences Shareholder Meeting

Conexeu Sciences Inc. has scheduled a Special Meeting of Stockholders for January 26, 2027, in Vancouver, Canada. The company established December 8, 2026, as the record date for stockholders entitled to notice and voting rights at the meeting.

4:37 PM ET 8-K
Capital Raise Vivani Medical, Inc. VANI

Vivani Medical Capital Raise of $5.1M

Vivani Medical entered into a share purchase agreement for a $5.1 million private placement of common stock with board members Gregg Williams and Aaron Mendelsohn. The shares were priced at $1.01 per share, representing an at-the-market transaction based on the prior trading day's close. Proceeds will be used to fund the clinical development of NPM-139, the company's semaglutide implant for weight maintenance.

Value
$5.1M
Counterparty
Gregg Williams and Aaron Mendelsohn
4:37 PM ET 8-K
Dividend DeFi Development Corp. DFDV

DeFi Development Dividend

DeFi Development Corp. declared daily cash dividends of $0.00530 per share on its Variable Rate Series C Perpetual Preferred Stock (CHAD) for the month of December 2026. The dividends will be paid for 22 business days, totaling approximately $186,707 in aggregate, representing a 14.00% per annum dividend rate. The company noted that these distributions are expected to be treated as a tax-free return of capital as it does not expect to generate earnings and profits in the foreseeable future.

Term
December 2026
4:37 PM ET 8-K
M&A Deal Standard Biotools Inc. LAB

Standard Biotools M&A Deal with Treeline Biosciences, Inc.

Standard BioTools Inc. provided a status update regarding its pending acquisition of Treeline Biosciences, Inc., specifically addressing stockholder litigation and demand letters. To avoid potential business delays and moot disclosure claims, the company issued supplemental disclosures to its definitive proxy statement ahead of the special meeting of stockholders scheduled for November 19, 2026.

Counterparty
Treeline Biosciences, Inc.
4:37 PM ET 8-K
Leadership Change Celanese Corp CE

Celanese Leadership Change

Celanese Corporation has elected Peter Matt to its Board of Directors, increasing the board size from 11 to 12 members. Mr. Matt currently serves as the President and CEO of Commercial Metals Company and brings over 40 years of experience in finance and global manufacturing leadership. He is expected to stand for re-election at the company's 2027 Annual Meeting of Shareholders.

4:37 PM ET 8-K
Leadership Change Medicinova Inc MNOV

Medicinova Leadership Change

Jason Kruger resigned as Chief Financial Officer, principal financial officer, and principal accounting officer effective November 10, 2026. In response, the Board appointed President and CEO Yuichi Iwaki to serve as interim CFO and acting principal financial/accounting officer until a successor is named. Dr. Iwaki will not receive additional compensation for the interim role.

4:36 PM ET 10-Q
Financial Results Dror Ortho-Design, Inc. DROR

Dror Ortho-Design Q3 2026 Results: Net Loss of $521K, Loss Narrows

Dror Ortho-Design, Inc. reported a net loss of $1,784,697 for the nine months ended September 30, 2026, compared to $1,988,989 in the prior year period. The company remains in the research and development stage with no revenue, and management has expressed substantial doubt about its ability to continue as a going concern due to an accumulated deficit of $23.8 million and negative working capital.

Key figure
Net loss $521K
4:36 PM ET Form 4
Insider Buying Third Coast Bancshares, Inc. TCBX

Third Coast Bancshares Insider Bart Caraway Buys $24.9K of Stock

Bart Caraway bought 638 shares of Third Coast Bancshares, Inc. at $39.02 a share, worth $24.9K in total on Nov 16, 2026. Shares held after the trade: 164,798 (+0.4%).

Value
$24.9K
Shares
638
Price
$39.02
Holding change
+0.4%
Trade date
Nov 16, 2026
4:36 PM ET Form 4
Insider Selling Onespaworld Holdings Ltd OSW

Onespaworld Holdings President, CFO and COO Stephen Lazarus Sells $5.36M of Stock

Stephen Lazarus, President, CFO and COO, sold 174,552 shares of Onespaworld Holdings Ltd at $30.51 to $30.85 a share (average $30.72) in 2 transactions, worth $5.36M in total between Nov 12, 2026 and Nov 13, 2026. Shares held after the trade: 216,513 (-23.2%).

Value
$5.36M
Shares
174,552
Average price
$30.72
Role
President, CFO and COO
Holding change
-23.2%
Trade date
Nov 12, 2026 to Nov 13, 2026
4:36 PM ET Form 4
Insider Selling Omnicom Group Inc. OMC

Omnicom Group Insider Linda Johnson Rice Sells $61.3K of Stock

Linda Johnson Rice sold 697 shares of Omnicom Group Inc. at $87.92 a share, worth $61.3K in total on Nov 12, 2026. Shares held after the trade: 11,824 (-5.6%).

Value
$61.3K
Shares
697
Price
$87.92
Holding change
-5.6%
Trade date
Nov 12, 2026
4:36 PM ET 10-Q
Financial Results Vulcan Infrastructure & Power Inc. VIP

Vulcan Infrastructure & Power Q3 2026 Results: Net Loss of $2.18M

Vulcan Infrastructure & Power Inc. filed its Form 10-Q on November 16, 2026, providing a quarterly update on its financial condition and results of operations. The filing includes condensed consolidated financial statements and management's discussion regarding the company's infrastructure and power project developments.

Key figure
Net loss $2.18M
4:36 PM ET 10-Q
Financial Results First Carolina Financial Services, Inc. FCBM

First Carolina Financial Services Q3 2026 Results: Turns Profitable, Net Income $7.9M

First Carolina Financial Services, Inc. reported its financial results for the quarter ended September 30, 2026, highlighting continued growth in net interest income and a stable credit profile. The filing emphasizes the company's strategic focus on community banking and maintaining strong capital ratios amidst evolving economic conditions.

Key figure
Net income $7.9M
4:35 PM ET Form 4
Insider Selling Insperity, Inc. NSP

Insperity Insider Tim Clifford Sells $260K of Stock

Tim Clifford sold 5,178 shares of Insperity, Inc. at $50.19 a share, worth $260K in total on Nov 13, 2026. Shares held after the trade: 23,935 (-17.8%).

Value
$260K
Shares
5,178
Price
$50.19
Holding change
-17.8%
Trade date
Nov 13, 2026
4:35 PM ET Form 4
Insider Selling CareDx, Inc. CDNA

CareDx Director Michael Goldberg Sells $1.09M of Stock

Michael Goldberg, Director, sold 13,800 shares of CareDx, Inc. at $78.32 to $79.85 a share (average $79.15) in 3 transactions, worth $1.09M in total on Nov 12, 2026. Shares held after the trade: 48,526 (-4.4%).

Value
$1.09M
Shares
13,800
Average price
$79.15
Role
Director
Holding change
-4.4%
Trade date
Nov 12, 2026
4:33 PM ET Form 4
Insider Selling CareDx, Inc. CDNA

CareDx CFO & COO Keith Kennedy Sells $166K of Stock

Keith Kennedy, CFO & COO, sold 2,097 shares of CareDx, Inc. at $78.78 to $79.61 a share (average $79.29) in 2 transactions, worth $166K in total on Nov 12, 2026. Shares held after the trade: 199,147 (-0.6%).

Value
$166K
Shares
2,097
Average price
$79.29
Role
CFO & COO
Holding change
-0.6%
Trade date
Nov 12, 2026
4:33 PM ET 10-Q
Financial Results MacKenzie Realty Capital, Inc. MKZR

MacKenzie Realty Capital Q1 2026 Results: Net Loss of $3.48M, Loss Widens

For the three months ended September 30, 2026, MacKenzie Realty Capital reported a net loss attributable to common stockholders of $4.54 million, or $1.64 per share, compared to a loss of $4.09 million in the prior year period. Total assets increased slightly to $236.99 million, while total equity declined to $75.91 million due to an increasing accumulated deficit and dividend distributions.

Key figure
Net loss $3.48M
4:33 PM ET 10-Q
Financial Results Smith Midland Corp SMID

Smith Midland Q3 2026 Results: Net Income $2.95M, Up 2.7% YoY

Smith-Midland Corporation reported total revenue of $22.8 million for the third quarter of 2026, a slight increase from $21.5 million in the prior year, driven by strong barrier rental growth. However, nine-month net income decreased significantly to $5.7 million compared to $10.4 million in 2025, primarily due to higher operating expenses and lower year-to-date barrier rental revenue.

Key figure
Net income $2.95M · +2.7% YoY
4:33 PM ET 10-Q
Financial Results Brookfield Oaktree Holdings, LLC OAK-PA

Brookfield Oaktree Holdings Q3 2026 Results: Net Income $27.5M, Down 58.7% YoY

Brookfield Oaktree Holdings, LLC reported a decrease in corporate investments from $1.43 billion at year-end 2025 to $1.23 billion as of September 30, 2026. The company maintained its status as a non-accelerated filer and reported 118,832,320 Class A units outstanding as of November 16, 2026.

Key figure
Net income $27.5M · -58.7% YoY
4:33 PM ET 10-Q
Financial Results Primeenergy Resources Corp PNRG

Primeenergy Resources Q3 2026 Results: Net Income $7.29M, Down 31.0% YoY

PrimeEnergy Resources Corporation is a non-accelerated filer and smaller reporting company with 1,574,500 shares of common stock outstanding as of November 16, 2026. The filing includes condensed consolidated financial statements for the period ending September 30, 2026, and highlights risks related to commodity price volatility and geopolitical instability.

Key figure
Net income $7.29M · -31.0% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.